Publications by authors named "Maxim Olsson"

Claim this Profile
A
Age and comorbidity in relation to treatment and survival outcomes in triple-negative breast cancer: A Swedish nationwide registry-based study.
Jenny Nyqvist-Streng, Josef Somi, Jari Martikainen, Maxim Olsson, Khalil Helou

J Geriatr Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers.
Peter Larsson, Maxim Olsson, Sithumini Sarathchandra, Anna Fäldt Beding, Eva Forssell-Aronsson

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties.
Peter Larsson, Maria Cristina De Rosa, Benedetta Righino, Maxim Olsson, Bogdan Iulius Florea

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.
Peter Larsson, Daniella Pettersson, Maxim Olsson, Sithumini Sarathchandra, Alexandra Abramsson

Cell Death Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes .
Maxim Olsson, Peter Larsson, Junko Johansson, Vasu R Sah, Toshima Z Parris

Front Cell Dev Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis